Neurocrine Biosciences, Inc.  today announced the presentation of new data from a clinician survey highlighting the functional impact experienced by patients with mild tardive dyskinesia (TD) severity ...

Learn about dyskinesia, including its causes, symptoms, types, and available treatment options to help manage involuntary ...

Learn how Huntington’s disease affects mood, including depression, anxiety, apathy, and irritability, plus treatment options and strategies for symptom management.

Over 90 percent of people with Huntington’s disease develop chorea. Learn about FDA-approved VMAT2 inhibitors, off-label medications, and lifestyle strategies to manage involuntary movements.

Research published in The Journal of Clinical Psychiatry characterizes patient-reported improvement with INGREZZA® (valbenazine) capsules across the KINECT® clinical ...

Huntington’s disease is a brain condition caused by a gene mutation. It typically develops between 30 and 50 years of age and causes movement issues such as chorea (involuntary dance-like movements), ...

CHILLICOTHE— Before seniors throw their caps in the air on graduation, they are getting dressed up to celebrate prom. At schools across the county, students are shining as they don their best dresses ...

In the wake of Anthropic’s announcement of its latest artificial intelligence model, Mythos, on April 7, the company has stood by an unusual decision: refusing to release it to the public. Not since ...

The rare illness affects an individual's ability to move and think, as well as their mental health Lexi Lane is a weekend banking writer at PEOPLE. She first joined as a member of the PEOPLE App team ...

Amy Aungst, center right, organizes walks in Cape Henlopen, Delaware, to raise awareness about Huntington’s disease, a rare condition that is estimated to affect about 30,000 or more U.S. adults.